{"id":60490,"date":"2024-10-12T12:06:09","date_gmt":"2024-10-12T12:06:09","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/10\/12\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/"},"modified":"2024-10-12T12:06:09","modified_gmt":"2024-10-12T12:06:09","slug":"ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/","title":{"rendered":"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform"},"content":{"rendered":"<div>\n<table name=\"logo_release\" border=\"0\" cellspacing=\"10\" cellpadding=\"5\" align=\"right\">\n<tbody>\n<tr>\n<td><img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2374018\/XtalPi_EN_Logo.jpg?p=medium600\" border=\"0\" alt=\"\" title=\"logo\" hspace=\"0\" vspace=\"0\" width=\"118\"><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span class=\"legendSpanClass\"><span class=\"xn-location\">CAMBRIDGE, Mass.<\/span><\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">Oct. 12, 2024<\/span><\/span> \/PRNewswire\/ &#8212; XtalPi, a global leader in AI drug discovery, announced today a\u00a0license agreement between Ailux Biologics, a division of XtalPi Inc., and Janssen Biotech, Inc.,(Janssen)\u00a0a Johnson &amp; Johnson company, on one of its proprietary biologics AI platforms. Under the agreement, Ailux Biologics grants Janssen and its affiliates a non-exclusive license to leverage its XtalFold&#x2122;\u00a0platform for the discovery and engineering of biologics. XtalFold&#x2122; is a proprietary AI-based software suite that provides rapid and accurate structural insights to accelerate biologics innovation across multiple phases. The agreement was facilitated by Johnson &amp; Johnson Innovation.<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder1\">\n<p style=\"TEXT-ALIGN: center; WIDTH: 100%\"> <a href=\"https:\/\/mma.prnasia.com\/media2\/2528536\/ailux.html\" target=\"_blank\" rel=\"nofollow noopener\"> <img decoding=\"async\" src=\"https:\/\/mma.prnasia.com\/media2\/2528536\/ailux.jpg?p=medium600\" title=\"\" alt=\"\"> <\/a> <br \/><span><\/span><\/p>\n<\/p><\/div>\n<p>XtalFold&#x2122; utilizes sequence information alone to model the interaction between biomolecules, which forms the foundation of biotherapeutics like monoclonal antibodies. In rigorous benchmark studies, XtalFold&#x2122; achieved state-of-the-art performance in terms of overall success rate and the quality of hard-to-model regions like the antibody-antigen interface. Since its launch one year ago, XtalFold&#x2122; has been fully validated in more than 30 partner and internal programs, delivering highly impactful results in a\u00a0variety of use cases, including antigen design, epitope identification, affinity maturation, pH-sensitivity\u00a0engineering, and bispecifics design.<\/p>\n<p><span class=\"xn-person\">Yi (Alex) Li<\/span>, VP of XtalPi and Head of Ailux Biologics, said: &#8220;Biologics are intricate machines that\u00a0operate in three-dimensional space. XtalFold&#x2122; enables the visualization and design of biologics in 3D space in real time, which could take months using currently available experimental approaches. We are\u00a0excited to share with Janssen this foundational technology, which has already proven transformative in-house.&#8221;<\/p>\n<p><b> About XtalPi<br \/><\/b><span id=\"spanHghlt1d19\">XtalPi (&#8220;QuantumPharm Inc.&#8221;, stock code: 2228.HK) is a quantum physics-based, AI-powered, and robotics-driven, innovative R&amp;D platform company. Established in 2015 by three postdoctoral physicists at\u00a0Massachusetts Institute of Technology\u00a0(<span class=\"xn-org\">MIT<\/span>), the company is dedicated to driving intelligent and digital transformation in the life sciences and materials sciences sectors. XtalPi combines quantum physics, AI, cloud computing, and large-scale robotics to provide R&amp;D solutions and services for biomedicine, chemical, renewable energy and advanced materials industries globally.<\/span><\/p>\n<p><b> About Ailux Biologics<br \/><\/b>Ailux\u00a0Biologics is a division of XtalPi\u00a0dedicated to the innovation in large molecule drug discovery. With a team of around 100 experts, Ailux has established a state-of-the-art biologics discovery lab, a proprietary database purpose-built for AI (AtlaX&#x2122;) and a trio of AI platforms, including a structure modeling suite (XtalFold&#x2122;), a generative large language model for proteins (XenProT&#x2122;) and a predictive AI suite for biologics (Xentient&#x2122;). Ailux partners with pharma and biotech companies to\u00a0accelerate their biologics programs with AI-powered, lab-validated solutions. To learn more, visit <a href=\"https:\/\/ailuxbio.com\/\" target=\"_blank\" rel=\"nofollow noopener\">https:\/\/ailuxbio.com\/<\/a> and follow @Ailux Biologics on Linkedin.<\/p>\n<p>\u00a0<\/p>\n<div class=\"PRN_ImbeddedAssetReference\" id=\"DivAssetPlaceHolder2\">\n<\/p><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass., Oct. 12, 2024 \/PRNewswire\/ &#8212; XtalPi, a global leader in AI drug discovery, announced today a\u00a0license agreement between Ailux Biologics, a division of XtalPi Inc., and Janssen Biotech, Inc.,(Janssen)\u00a0a Johnson &amp; Johnson company, on one of its proprietary biologics AI platforms. Under the agreement, Ailux Biologics grants Janssen and its affiliates a non-exclusive [&#8230;]\n","protected":false},"author":1,"featured_media":85254,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-60490","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass., Oct. 12, 2024 \/PRNewswire\/ &#8212; XtalPi, a global leader in AI drug discovery, announced today a\u00a0license agreement between Ailux\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-10-12T12:06:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnasia.com\/media2\/2374018\/XtalPi_EN_Logo.jpg?p=medium600\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform\",\"datePublished\":\"2024-10-12T12:06:09+00:00\",\"dateModified\":\"2024-10-12T12:06:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/\"},\"wordCount\":447,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/\",\"name\":\"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-10-12T12:06:09+00:00\",\"dateModified\":\"2024-10-12T12:06:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/","og_locale":"en_US","og_type":"article","og_title":"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform","og_description":"CAMBRIDGE, Mass., Oct. 12, 2024 \/PRNewswire\/ &#8212; XtalPi, a global leader in AI drug discovery, announced today a\u00a0license agreement between Ailux","og_url":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-10-12T12:06:09+00:00","og_image":[{"url":"https:\/\/mma.prnasia.com\/media2\/2374018\/XtalPi_EN_Logo.jpg?p=medium600"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform","datePublished":"2024-10-12T12:06:09+00:00","dateModified":"2024-10-12T12:06:09+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/"},"wordCount":447,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/","url":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/","name":"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-10-12T12:06:09+00:00","dateModified":"2024-10-12T12:06:09+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/ailux-biologics-a-division-of-xtalpi-enters-into-a-license-agreement-with-janssen-biotech-on-biologics-ai-platform\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"Ailux Biologics, a Division of XtalPi, Enters into a License Agreement with Janssen Biotech on Biologics AI Platform"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/60490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=60490"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/60490\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/85254"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=60490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=60490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=60490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}